2009
DOI: 10.1186/1471-244x-9-28
|View full text |Cite
|
Sign up to set email alerts
|

A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder

Abstract: Background: Topiramate might be effective in the treatment of posttraumatic stress disorder (PTSD) because of its antikindling effect and its action in both inhibitory and excitatory neurotransmitters. Open-label studies and few controlled trials have suggested that this anticonvulsant may have therapeutic potential in PTSD. This 12-week randomized, double-blind, placebo-controlled clinical trial will compare the efficacy of topiramate with placebo and study the tolerability of topiramate in the treatment of P… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
0
1

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 34 publications
1
4
0
1
Order By: Relevance
“…Total-I and Total-C of the Nanai people showed significantly strong correlations but were not identical, which was in good accordance with a previous report [28]. However, both seemed to be high compared with previous reports [22][23][24]26]. The ethnic minority status of the Nanai may increase the likelihood of adverse outcomes [13][14][15].…”
Section: Discussionsupporting
confidence: 84%
See 1 more Smart Citation
“…Total-I and Total-C of the Nanai people showed significantly strong correlations but were not identical, which was in good accordance with a previous report [28]. However, both seemed to be high compared with previous reports [22][23][24]26]. The ethnic minority status of the Nanai may increase the likelihood of adverse outcomes [13][14][15].…”
Section: Discussionsupporting
confidence: 84%
“…Estimation of total severity scores was performed by summing the frequency and intensity ratings with Total-C ranging from 0 to 136. Total-C was classified as follows: subclinical = 0-19, mild = 20-39, moderate = 40-59, severe = 60-79, and extremely severe C80 [26].…”
Section: Caps (Russian Language Certified Version)mentioning
confidence: 99%
“…Due to an expected refusal rate of 20%, and in order to increase the likelihood of identifying post-traumatic stress disorder cases, the three strata with the highest homicide rates were oversampled, resulting in 1500 interviews. In Sao Paulo, we expected to identify approximately 120 current cases to be referred to a case-control study [23] and to a clinical trial [24] on post-traumatic stress disorder (PTSD). As we expected a 5% one-year prevalence of PTSD, we decided to increase the sample size to 3,000 interviews to allow for the identification of the required PTSD cases.…”
Section: Methodsmentioning
confidence: 99%
“…Several cutoff points have been reported as follows: for Total-I, scores ≥25 indicate persons at high risk of PTSD [ 15 , 16 ] and scores ≥34 indicate probable or confirmed PTSD cases [ 15 , 16 ]; additionally, for Total-C, scores of 20–39 indicate mild PTSD [ 17 ] and scores of 40–59 indicate moderate PTSD [ 17 ]. To separate the participants into four groups, cutoff scores of 34 (for the Total-I) and 40 (for the Total-C) were used as cutoffs in the present study; individuals with low Total-I scores (<34) and low Total-C scores (<40) were categorized into the LL group; those with low Total-I scores (<34) and high Total-C scores (≥40) were categorized into the LH group; those with high Total-I scores (≥34) and low Total-C scores (<40) were categorized into the HL group, and those with high Total-I scores (≥34) and high Total-C scores (≥40) were categorized into the HH group.…”
Section: Methodsmentioning
confidence: 99%